Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014566 |
| CAS No | 364745-13-1 |
| Mol.F. | C8H4N2O3 |
| Mol.Wt. | 176.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014567 |
| CAS No | NA |
| Mol.F. | C19H17ClN4O6S |
| Mol.Wt. | 464.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014568 |
| CAS No | NA |
| Mol.F. | C49H52F2N10O8 |
| Mol.Wt. | 947.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014569 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014570 |
| CAS No | NA |
| Mol.F. | C49H53F2N9O7 |
| Mol.Wt. | 918.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014571 |
| CAS No | NA |
| Mol.F. | C16H18N2O |
| Mol.Wt. | 254.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014572 |
| CAS No | NA |
| Mol.F. | C16H19N5O4S |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014573 |
| CAS No | NA |
| Mol.F. | C13H20N2O4 |
| Mol.Wt. | 268.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014574 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014575 |
| CAS No | NA |
| Mol.F. | C20H23N9O8 |
| Mol.Wt. | 517.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014576 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014577 |
| CAS No | NA |
| Mol.F. | C20H20N8O8 |
| Mol.Wt. | 500.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014578 |
| CAS No | NA |
| Mol.F. | C20H19N9O9 |
| Mol.Wt. | 529.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014579 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014580 |
| CAS No | NA |
| Mol.F. | C11H11Cl2N3O2 |
| Mol.Wt. | 288.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014581 |
| CAS No | 2518136-84-8 |
| Mol.F. | C11H13ClN2O |
| Mol.Wt. | 224.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |